Mochida Pharmaceutical Co., Ltd. (FRA:MFY)

Germany · Delayed Price · Currency is EUR

16.70

0.00 (0.00%)

At close: Jun 26, 2026

-2.34% (1Y)

Market Cap	602.76M -6.4%
Revenue (ttm)	637.91M +11.2%
Net Income	43.11M +39.0%
EPS	1.22 +39.0%
Shares Out	n/a
PE Ratio	13.98
Forward PE	n/a
Dividend	0.45 (2.59%)
Ex-Dividend Date	Mar 30, 2026

Volume	n/a
Open	16.70
Previous Close	16.70
Day's Range	16.70 - 16.70
52-Week Range	16.20 - 21.80
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 3, 2026

About Mochida Pharmaceutical

Mochida Pharmaceutical Co., Ltd. manufactures and sells pharmaceuticals and healthcare products in Japan. It offers pharmaceuticals products for the treatment of cardiovascular, obstetrics, gynecology, dermatology, psychiatry, and gastroenterology, including Lialda, Omvoh, and Cortiment for the treatment of ulcerative colitis; Goofice and Movicol for the treatment of chronic constipation; Epadel for hyperlidemia and arteriosclerosis obliterans; Urece for gout and hyperuricemia; Treprost for the treatment of pulmonary arterial hypertension and p... [Read more]

Industry Pharmaceutical Preparations

Founded 1913

Employees 1,508

Stock Exchange Frankfurt Stock Exchange

Ticker Symbol MFY

Financial Performance

In fiscal year 2026, Mochida Pharmaceutical's revenue was 116.95 billion, an increase of 11.21% compared to the previous year's 105.16 billion. Earnings were 7.90 billion, an increase of 39.01%.

Financial numbers in JPY Financial Statements